Atherectomy Devices Market by Type (Directional Atherectomy Devices, Rotational Atherectomy Devices, Laser Atherectomy Devices), by Application (Coronary Artery Disease, Peripheral Artery Disease, Carotid Artery Disease), by End-Use Industry (Hospitals, Ambulatory Surgical Centers, Cardiovascular Clinics); Global Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Atherectomy Devices Market was valued at USD 2.3 billion in 2023 and will surpass USD 4.6 billion by 2030; growing at a CAGR of 10.6% during 2024 - 2030. The atherectomy devices market is rapidly growing as advancements in medical technologies are enabling more effective treatments for vascular diseases. These devices are primarily used for the removal of plaque from arteries, a procedure that is critical in the treatment of a variety of arterial diseases, including coronary artery disease, peripheral artery disease, and carotid artery disease. As cardiovascular diseases become increasingly prevalent worldwide, the demand for atherectomy devices is expected to rise, driven by the growing awareness of early detection and treatment of vascular conditions. The technological innovations in atherectomy devices are focused on improving patient outcomes, reducing recovery times, and enhancing the precision of plaque removal. Directional Atherectomy Devices Are Largest Owing to Precision in Treatment Directional atherectomy devices dominate the market due to their precision in plaque removal, especially in coronary artery disease treatment. These devices use a catheter with a rotating blade to excise plaque from the vessel walls, offering high control and effectiveness during procedures. Directional atherectomy is particularly favored in treating coronary arteries because it allows for more targeted removal of plaque, minimizing damage to surrounding healthy tissue. The versatility and effectiveness in a variety of cases make it the most commonly used type, driving its large market share. Rotational Atherectomy Devices Are Fastest Growing Owing to Technological Advancements Rotational atherectomy devices are experiencing the fastest growth in the market, driven by ongoing technological advancements. These devices use a diamond-coated burr that rotates at high speeds to grind down harder, calcified plaques in arteries. As patients with advanced atherosclerosis and calcified plaques become more prevalent, rotational atherectomy is becoming the go-to option for treating complex cases. The growing incidence of severe vascular diseases, especially among the aging population, is propelling the demand for these devices, making them the fastest-growing subsegment in the atherectomy device market. Coronary Artery Disease Application is Largest Owing to High Prevalence Coronary artery disease (CAD) holds the largest market share in atherectomy device applications, owing to the high prevalence of the disease. CAD is the most common type of heart disease, resulting in the narrowing or blockage of coronary arteries due to the buildup of plaque. As the number of CAD cases continues to rise globally, atherectomy devices designed specifically for coronary artery disease are in high demand. Early detection and intervention through atherectomy procedures are critical in preventing heart attacks, contributing to the robust growth of the coronary artery disease application in the atherectomy devices market. Hospitals Are Largest End-User Industry Due to Volume of Procedures Hospitals are the largest end-user segment for atherectomy devices, accounting for the majority of procedures. Hospitals have the necessary infrastructure, skilled professionals, and equipment to perform complex atherectomy procedures, especially in high-risk cases such as those involving coronary or peripheral artery disease. The increasing hospitalizations due to vascular diseases and the growing healthcare infrastructure worldwide are fueling the demand for atherectomy devices in this segment. Hospitals also offer comprehensive care, making them the primary setting for these critical procedures. North America is Largest Region Owing to Advanced Healthcare Infrastructure North America holds the largest share of the atherectomy devices market, driven by the region's advanced healthcare infrastructure and a high prevalence of cardiovascular diseases. The United States, in particular, accounts for a significant portion of the market due to its well-established healthcare system, high healthcare expenditure, and widespread adoption of cutting-edge medical technologies. The growing awareness of cardiovascular diseases and the increased focus on early diagnosis and treatment are propelling the demand for atherectomy devices in the region. Additionally, the availability of trained professionals and advanced medical equipment makes North America the leading market for these devices. Leading Companies and Competitive Landscape The atherectomy devices market is highly competitive, with several prominent players leading the industry. Companies such as Medtronic, Boston Scientific, and Abbott Laboratories are at the forefront, constantly innovating and expanding their product offerings to meet the growing demand for minimally invasive cardiovascular treatments. These companies focus on enhancing the effectiveness, safety, and precision of atherectomy devices, with ongoing investments in research and development. Strategic partnerships, acquisitions, and technological advancements are key strategies employed by these market leaders to maintain their competitive edge. The market is also characterized by the entry of new players, which contributes to the dynamic competitive landscape. Recent Developments: • Boston Scientific Corporation announced the launch of a next-generation rotational atherectomy device, designed to enhance precision and safety in treating coronary artery disease. • Medtronic plc received FDA approval for its new orbital atherectomy system, aimed at improving outcomes for patients with peripheral artery disease by enhancing plaque removal. • Johnson & Johnson's Abbott Vascular launched a new laser atherectomy device, offering better outcomes in treating complex coronary blockages with minimal risk of injury. • Avinger, Inc. reported the successful completion of a clinical trial for its new atherectomy catheter, designed to provide more effective plaque removal in patients with peripheral artery disease. • Cardiovascular Systems, Inc. announced an expansion of its atherectomy product line with the introduction of a new directional atherectomy device designed for treating complex coronary lesions. List of Leading Companies: • Boston Scientific Corporation • Medtronic plc • Johnson & Johnson (Abbott Vascular) • Philips Healthcare • Avinger, Inc. • Cardiovascular Systems, Inc. • Terumo Corporation • Edwards Lifesciences Corporation • Spectranetics (Acquired by Phillips) • Straub Medical AG • Volcano Corporation (Acquired by Philips Healthcare) • Asahi Intecc Co., Ltd. • Endologix, Inc. • Biotronik SE & Co. KG • Abbott Laboratories Report Scope: Report Features Description Market Size (2023) USD 2.3 Billion Forecasted Value (2030) USD 4.6 Billion CAGR (2024 – 2030) 10.6% Base Year for Estimation 2023 Historic Year 2022 Forecast Period 2024 – 2030 Report Coverage Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments Segments Covered Atherectomy Devices Market by Type (Directional Atherectomy Devices, Rotational Atherectomy Devices, Laser Atherectomy Devices), by Application (Coronary Artery Disease, Peripheral Artery Disease, Carotid Artery Disease), by End-Use Industry (Hospitals, Ambulatory Surgical Centers, Cardiovascular Clinics) Regional Analysis North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) Major Companies Boston Scientific Corporation, Medtronic plc, Johnson & Johnson (Abbott Vascular), Philips Healthcare, Avinger, Inc., Cardiovascular Systems, Inc., Edwards Lifesciences Corporation, Spectranetics (Acquired by Phillips), Straub Medical AG, Volcano Corporation (Acquired by Philips Healthcare), Asahi Intecc Co., Ltd., Endologix, Inc., Abbott Laboratories Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements